- Home
- VERA vs ACHC Comparison
VERA vs ACHC Comparison
Compare VERA & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- ACHC
- Stock Information
- Founded
- VERA 2016
- ACHC 2005
- Country
- VERA United States
- ACHC United States
- Employees
- VERA N/A
- ACHC N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- VERA Health Care
- ACHC Health Care
- Exchange
- VERA Nasdaq
- ACHC Nasdaq
- Market Cap
- VERA 1.4B
- ACHC 1.7B
- IPO Year
- VERA 2021
- ACHC N/A
- Fundamental
- Price
- VERA $21.27
- ACHC $20.60
- Analyst Decision
- VERA Buy
- ACHC Strong Buy
- Analyst Count
- VERA 8
- ACHC 10
- Target Price
- VERA $64.29
- ACHC $42.85
- AVG Volume (30 Days)
- VERA 1.2M
- ACHC 2.4M
- Earning Date
- VERA 08-05-2025
- ACHC 08-05-2025
- Dividend Yield
- VERA N/A
- ACHC N/A
- EPS Growth
- VERA N/A
- ACHC N/A
- EPS
- VERA N/A
- ACHC 1.52
- Revenue
- VERA N/A
- ACHC $3,229,609,000.00
- Revenue This Year
- VERA N/A
- ACHC $7.80
- Revenue Next Year
- VERA N/A
- ACHC $8.56
- P/E Ratio
- VERA N/A
- ACHC $13.56
- Revenue Growth
- VERA N/A
- ACHC 5.64
- 52 Week Low
- VERA $18.53
- ACHC $17.13
- 52 Week High
- VERA $51.61
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- VERA 48.60
- ACHC 45.41
- Support Level
- VERA $19.07
- ACHC $17.13
- Resistance Level
- VERA $22.74
- ACHC $21.00
- Average True Range (ATR)
- VERA 0.97
- ACHC 1.20
- MACD
- VERA 0.13
- ACHC -0.05
- Stochastic Oscillator
- VERA 59.99
- ACHC 55.08
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.